Recurrent anaphylaxis to a gelatin-based colloid plasma substitute and to cetuximab following sensitisation to galactose-alpha-1,3-galactose.Serrier J, Khoy K, Ollivier Y, Gervais R, Le Moel G, et al.British journal of anaesthesia • 2021-Jun-01View on PubMed →DOI →